 |
BotoxMore precisely, on April 15, 2002, FDA approved botulinum toxin type A (BOTOX) to temporarily improve the appearance of moderate-to-severe frown lines between the eyebrows (glabellar lines). It has been stated that injections with botulinum to decrease the appearance of facial wrinkles is the most popular cosmetic procedure, according to the American Society for Aesthetic Plastic Surgery, in the U.S. as of early 2006. 3.3 million botox procedures for this purpose were reported during 2005. In it's essence, this is a procedure that can temporarily smooth moderate to severe frown lines between brows with no surgery and no recovery time. Service providers for this treatment promise an improvement that can be seen within days, lasting for up to 4 months. Botox - StudiesBrin MF, Lew MF, Adler CH, Comella CL, Factor SA, Jankovic J, O'Brien C, Murray JJ, Wallace JD, Willmer-Hulme A, Koller M (1999). "Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia". Neurology 53 (7): 1431-8.
|